I was expecting more from this trading halt (i.e. royalty or partnership) as per the bullet points in the recent presentation for item 4 Strengthen Financial position overall. However based on information in financial slide this raise should cover 12 month spend without taking into account the trial costs for CLBP, so perhaps 6-9 months before more funds required.
Would any partner pay up whilst Oaktree still has the loan conditions? So does this keep it all rolling till potential FDA approval and then all other items on the table?
Ann: MSB Launches Entitlement Offer and Placement, page-129
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.005(0.32%) |
Mkt cap ! $1.798B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.52 | $6.446M | 4.092M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 62215 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 14678 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |